Valuation: Guizhou Bailing Group Pharmaceutical Co., Ltd.

Market Cap 6.14B 907M 795M 735M 676M 1.28B 87.47B 1.3B 8.79B 3.44B 42.8B 3.41B 3.33B 147B P/E 2024
193x
P/E 2025 -54.4x
Enterprise Value 7.02B 1.04B 908M 840M 772M 1.46B 99.93B 1.48B 10.04B 3.94B 48.89B 3.89B 3.81B 168B EV / Sales 2024
1.74x
EV / Sales 2025 2.23x
Free-Float
67.53%
Yield 2024 *
-
Yield 2025 -
1 week-0.22%
Current month+3.69%
1 month+5.63%
3 months-12.96%
6 months+5.39%
Current year+3.45%
1 week 4.44
Extreme 4.44
4.83
1 month 4.21
Extreme 4.21
4.91
Current year 4.08
Extreme 4.08
5.47
1 year 4.08
Extreme 4.08
6.94
3 years 2.98
Extreme 2.98
8.8
5 years 2.98
Extreme 2.98
11.97
10 years 2.98
Extreme 2.98
25.83
Manager TitleAgeSince
Chief Executive Officer 56 2015-04-01
Director of Finance/CFO 41 2020-12-28
Corporate Officer/Principal 42 2014-01-26
Director TitleAgeSince
Director/Board Member 58 2007-12-24
Chairman 56 2026-03-26
Director/Board Member 42 2014-01-26
Date Insider Type Main position Quantity % Market Cap.
9/21/20 Sell

Chairman

1,940,600 0.2495%
9/18/20 Sell

Chairman

296,500 0.0381%
9/18/20 Sell

Director

3,670,000 0.4719%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-0.22%-16.04%-45.12% 906M
+1.21%+6.60%-7.45%-3.61% 13.54B
+1.23%+11.32%-26.78%-49.32% 5.27B
+1.06%+8.27%+1.69%-2.80% 4.72B
+6.67%+13.48%+15.79%-27.42% 4.07B
+2.51%+4.89%+6.61%-5.89% 3.75B
+2.10%+11.85%-2.90%-1.87% 3.57B
+4.42%+14.06%-0.86%+12.07% 3.39B
+1.74%+2.19%-11.61%-20.77% 2.42B
+1.79%+4.97%-0.13%+53.23% 1.86B
Average +2.27%+2.90%-4.17%-9.15% 4.35B
Weighted average by Cap. +2.17%+3.75%-4.63%-9.51%

Financials

2024 2025
Net sales 3.83B 565M 495M 458M 421M 794M 54.48B 807M 5.47B 2.15B 26.65B 2.12B 2.07B 91.83B 3.05B 450M 395M 365M 335M 633M 43.41B 643M 4.36B 1.71B 21.24B 1.69B 1.65B 73.18B
Net income 33.62M 4.97M 4.35M 4.02M 3.7M 6.98M 479M 7.09M 48.1M 18.86M 234M 18.64M 18.24M 807M -104M -15.41M -13.51M -12.49M -11.48M -21.67M -1.49B -22.02M -149M -58.53M -727M -57.87M -56.61M -2.51B
Net Debt 1.4B 207M 181M 168M 154M 291M 19.94B 295M 2B 785M 9.76B 777M 760M 33.62B 875M 129M 113M 105M 96.25M 182M 12.46B 185M 1.25B 491M 6.09B 485M 474M 21B
Logo Guizhou Bailing Group Pharmaceutical Co., Ltd.
Guizhou Bailing Group Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of Miao medicine. The Company operates four segments. The Industrial segment is mainly engaged in the research and development, production and sales of Chinese patent medicine tablets, capsules and syrups. The Commercial segment is mainly engaged in drug distribution and big health business. The Medical Institution segment mainly operates diabetes hospitals. Other segment mainly provides Chinese medicinal materials and are engaged in organic fertilizer manufacturing, water production and supply and other businesses. The Company's products include Yindan Xinnaotong soft capsules, Kesuting syrup and capsules, Shuangyang Houbitong granules and non-Miao medicine products Jingan capsules, Vitamin C Yinqiao tablets, Xiaoer Chaigui antipyretic granules and other products. The Company mainly conducts its businesses in the domestic market.
Employees
5,715
Date Price Change Volume
26-07-19 CN¥4.500 0.00% 7,895,900
26-07-17 CN¥4.500 -4.26% 11,552,400
26-07-16 CN¥4.700 -1.05% 10,770,900
26-07-15 CN¥4.750 +3.04% 14,747,703
26-07-14 CN¥4.610 +1.10% 10,158,604

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002424 Stock